In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Par Pharmaceutical

Division of Endo International PLC
www.parpharm.com/generics.php

Latest From Par Pharmaceutical

Lupin’s ProAir Rival Has 'Moved Ahead' Despite CRL

Lupin is staring at stretched launch timelines in the US for its generic ProAir following a Complete Response Letter, but the company maintains that its application has progressed and the market opportunity for the product remains attractive.

Regulation Generic Drugs

US Setback For Lupin’s GxProAir But Application Has 'Moved Ahead'

Lupin is staring at stretched launch timelines in the US for its generic ProAir following a Complete Response Letter, but the company maintains that its application has progressed and the market opportunity for the product remains attractive.

Policy & Regulation India

Par Prepares To Offer First Orfadin Rival With Improved Storage

By being able to be stored at room temperature, Par’s first generic of Sobi’s Orfadin nitisinone capsules offer a competitive advantage over the reference brand.

Launches United States

Behind-The-Scenes Battles As Opioid MDL Jury Trial Nears

Expert witness "battle plan," requests for summary judgment, and squabble over DEA drug distribution data offer preview of the first US bellwether trial against opioid manufacturers, distributors and pharmacies.

 
Legal Issues Advertising, Marketing & Sales
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register